Anthracycline antineoplastic agents encapsulated in...

Details Anthracycline antineoplastic agents encapsulated in... Anthracycline antineoplastic agents encapsulated in...

A - Human Necessities

61

K

167/182

A61K 9/50 (2006.01) A61K 9/127 (2006.01) A61K 31/70 (2006.01) C07H 15/252 (2006.01)

Patent

CA 1272686

ABSTRACT Formulations consisting of phospholipid micellular particles encapsulating anthracycline anti-neoplastic agents and methods for using such compositions to treat neoplastic tumors are described. In a preferred embodiment, the particles are in the form of vesicles which comprise an anthracycline agent, preferably daunorubicin, distearoyl phosphatidyl choline, distearoyl phosphatidyl glycerol and cholesterol, preferably in the ratio of about 1:4:5:6 to about 1:4:20:20. The vesicles are suspended in a low ionic solution such as 5% dextrose at pH 7.4 and may be administered to humans to deliver the anthracycline to treat neoplastic tumors.

503851

Affiliated with

Also associated with

Rating

Anthracycline antineoplastic agents encapsulated in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anthracycline antineoplastic agents encapsulated in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthracycline antineoplastic agents encapsulated in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1329052